Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha
about
A comprehensive manually curated reaction map of RANKL/RANK-signaling pathwayOsteoclasts: what do they do and how do they do it?Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulationNF-kappaB and the regulation of hematopoiesisThe LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast developmentRole of denosumab in prostate cancer.Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of OsteoclastogenesisNF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritisWITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathwayConstitutively active canonical NF-κB pathway induces severe bone loss in mice.RANKL signaling and osteoclastogenesis is negatively regulated by cardamoninOsteoclasts; culprits in inflammatory osteolysis.Osteopetrosis in TAK1-deficient mice owing to defective NF-κB and NOTCH signaling.Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathyNF-κB-Mediated Regulation of OsteoclastogenesisRole of NF-κB in the skeletonButein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signalingRecommendations for control of pathogens and infectious diseases in fish research facilities.RNA therapeutics targeting osteoclast-mediated excessive bone resorption.Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysisNLRP12 provides a critical checkpoint for osteoclast differentiationThiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.Role of nuclear factor-kappaB in the immune system and bone.RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.Documented and potential research impacts of subclinical diseases in zebrafish.Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.Inflammation, cancer, and bone loss.Immune regulation of bone loss by Th17 cells.Dento-craniofacial phenotypes and underlying molecular mechanisms in hypohidrotic ectodermal dysplasia (HED): a review.NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.NF-κB signaling and bone resorption.Functions of nuclear factor kappaB in bone.Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.Identification of microRNAs in human circulating monocytes of postmenopausal osteoporotic Mexican-Mestizo women: A pilot study.Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
P2860
Q24599024-1A9FC2D5-9EDE-45E4-935A-E31876253CF9Q24683898-B9F0F3EB-2DAE-42F2-8C7D-BE29B20A5E25Q27334016-B71C2115-39EA-465B-B8BF-A3C8EF71A09CQ28301261-CA08A583-ADA3-4F64-9ACC-B3B542BB4645Q28512132-7897B15C-8389-4F14-BFAA-0C818C6C581AQ30455154-BDBDED1A-998D-4B67-B89B-44E70489DB0EQ33711211-59BAF893-7A11-4754-BE44-2B1D1A177254Q33840418-83FF0CD6-8D84-4668-BDA7-321D21FA5554Q34241611-19B145CF-C5D7-4A3F-8D0C-B6EE4B3C4DBEQ34279869-8B699345-40BC-491F-91C2-5318EAC274A1Q34299726-EAE48FA5-0E1E-4387-B180-BB5A25C66D84Q34731280-38CAE3BE-91CD-4FFD-991B-62E016BED0AEQ34896003-0DA9ECF9-C819-4E67-ACB6-0A6B41EC5243Q34926779-258AD0AB-3CC9-4F34-A1B3-61EEDEBA46CAQ35087950-0C980285-DB15-4E62-81AB-2C213EAF8CBFQ35123561-7F95998F-E5B9-46AF-98A5-6FAF4D93D45FQ35260971-6F33423B-F402-4051-BEDD-B391AF895061Q35347883-F8EE2611-6DD3-412B-9153-1D6A7C723DA8Q35511177-DC83D5FC-5CA8-4C56-B16A-670AB765811FQ35725708-DD0AD958-808E-4C4A-AA23-50616D8A6402Q35800463-A0DEB9B9-1F5D-48C1-B803-52E3650F724BQ35860271-7D298443-82C5-4510-8820-FD4B89BF6219Q35989917-B412D629-72F0-4B0B-89C0-CD17E158A227Q36147288-8270715B-2B85-4C76-8BF0-D7DBBB6DBE5FQ36324929-CD2C0E0C-4612-4512-8BD6-8A46A5F37884Q36499078-FD9FFEAD-2F04-43FD-B782-F41409496D01Q36990674-F68ED325-1434-4B04-9621-42C5AEF3B9D6Q37118770-732415CE-DE70-4388-A3FD-9409EF57F1F1Q37316183-ED35DDF2-194D-4B3F-B28F-728D05206FA8Q37317215-F2081EC8-6426-49F9-A0A9-94563BEFFAB1Q37333361-1A4C9115-4D31-4238-AAA9-E1238D3035F9Q37363042-B6323C10-422B-4CC2-92AC-609548A2A5A4Q37449635-A0FAE522-FA36-4C4E-A706-72D82AE0D271Q37730952-C62F09DD-ACDE-41B6-80C4-99A265E893FBQ39758262-3495728F-9D64-4DC4-A7BC-E7D9AA053752Q39812715-EF8E76E3-F7EB-47C8-BB23-066C7BA60BB4Q41882531-E0EFB054-D61B-4770-8338-EC0233F8AB51Q42426515-23AFC390-0123-43CA-9145-3D558F23A186Q47159640-BF895196-0539-457A-B691-13534DFAF256Q49891124-4C98E92C-F638-4B90-AE0E-27369267BF42
P2860
Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha
description
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im Dezember 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/12/24)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/12/24)
@nl
наукова стаття, опублікована в грудні 2004
@uk
name
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@ast
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@en
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@nl
type
label
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@ast
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@en
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@nl
prefLabel
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@ast
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@en
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@nl
P2093
P2860
P921
P356
P1476
Osteoclast differentiation is ...... ibitor of kappa B kinase alpha
@en
P2093
Allison P. Armstrong
Daniel G. Branstetter
Jonathan M. Derry
Kiyoshi Takeda
Mark E. Tometsko
Michelle L. Chaisson
William C. Dougall
P2860
P304
54841–54848
P356
10.1074/JBC.M406392200
P407
P50
P577
2004-12-24T00:00:00Z